West Pharmaceutical Services Other Operating Income or Expenses 2010-2025 | WST
West Pharmaceutical Services annual/quarterly other operating income or expenses history and growth rate from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- West Pharmaceutical Services other operating income or expenses for the quarter ending March 31, 2025 were $-0.021B, a 564.52% increase year-over-year.
- West Pharmaceutical Services other operating income or expenses for the twelve months ending March 31, 2025 were $-0.039B, a 78.24% increase year-over-year.
- West Pharmaceutical Services annual other operating income or expenses for 2024 were $-0.021B, a 33.12% decline from 2023.
- West Pharmaceutical Services annual other operating income or expenses for 2023 were $-0.031B, a 17.16% increase from 2022.
- West Pharmaceutical Services annual other operating income or expenses for 2022 were $-0.027B, a 239.24% increase from 2021.
West Pharmaceutical Services Annual Other Operating Income or Expenses
(Millions of US $) |
| 2024 |
$-21 |
| 2023 |
$-31 |
| 2022 |
$-27 |
| 2021 |
$-8 |
| 2020 |
$-12 |
| 2019 |
$3 |
| 2018 |
$-2 |
| 2017 |
$-2 |
| 2016 |
$-30 |
| 2015 |
$-60 |
| 2014 |
$0 |
| 2013 |
$1 |
| 2012 |
$-1 |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$0 |
West Pharmaceutical Services Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2025-03-31 |
$-21 |
| 2024-12-31 |
$-10 |
| 2024-09-30 |
$-4 |
| 2024-06-30 |
$-3 |
| 2024-03-31 |
$-3 |
| 2023-12-31 |
$-9 |
| 2023-09-30 |
$-6 |
| 2023-06-30 |
$-4 |
| 2023-03-31 |
$-13 |
| 2022-12-31 |
$-31 |
| 2022-09-30 |
$-2 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$-5 |
| 2021-09-30 |
$-2 |
| 2021-06-30 |
$3 |
| 2021-03-31 |
$-4 |
| 2020-12-31 |
$-6 |
| 2020-09-30 |
$-7 |
| 2020-06-30 |
$-3 |
| 2020-03-31 |
$4 |
| 2019-12-31 |
$4 |
| 2019-09-30 |
$-6 |
| 2019-06-30 |
$3 |
| 2019-03-31 |
$2 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$0 |
| 2018-06-30 |
$-1 |
| 2018-03-31 |
$-3 |
| 2017-12-31 |
$1 |
| 2017-09-30 |
$10 |
| 2017-06-30 |
$-12 |
| 2017-03-31 |
$-1 |
| 2016-12-31 |
$-1 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-1 |
| 2016-03-31 |
$-26 |
| 2015-12-31 |
$-2 |
| 2015-09-30 |
$-49 |
| 2015-06-30 |
$-10 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$2 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$-1 |
| 2013-12-31 |
$0 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$15.478B |
$2.893B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
